AAAAAA

   
Results: 1-15 |
Results: 15
Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy
Authors: Sato, S Yajima, A Sasaki, H Mizutani, K Honjo, H Yamamoto, K Ozaki, M Hasegawa, K Kudo, T Yakushiji, M Hatae, M Noda, K
Citation: S. Sato et al., Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy, ONCOL REP, 8(2), 2001, pp. 239-244
Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer
Authors: Yamamoto, K Noda, K Hatae, M Kudo, T Hasegawa, K Nishimura, R Honjo, H Yajima, A Sato, S Mizutani, K Yakushiji, M Terashima, Y Ochiai, K Sasaki, H Ozaki, M
Citation: K. Yamamoto et al., Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer, ONCOL REP, 8(2), 2001, pp. 273-277
A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study
Authors: Katsumata, N Tsunematsu, R Tanaka, K Terashima, Y Ogita, S Hoshiai, H Kohno, I Hirabayashi, K Yakushiji, M Noda, K Taguchi, T
Citation: N. Katsumata et al., A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study, ANN ONCOL, 11(12), 2000, pp. 1531-1536
Serum MAGE-4 protein in ovarian cancer patients
Authors: Kawagoe, H Yamada, A Matsumoto, H Ito, M Ushijima, K Nishida, T Yakushiji, M Itoh, K
Citation: H. Kawagoe et al., Serum MAGE-4 protein in ovarian cancer patients, GYNECOL ONC, 76(3), 2000, pp. 336-339
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer
Authors: Sugiyama, T Yakushiji, M Noda, K Ikeda, M Kudoh, R Yajima, A Tomoda, Y Terashima, Y Takeuchi, S Hiura, M Saji, F Takahashi, T Umesaki, N Sato, S Hatae, M Ohashi, Y
Citation: T. Sugiyama et al., Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer, ONCOL-BASEL, 58(1), 2000, pp. 31-37
Phase II clinical study on the effects of recombinant human interleukin-3 on thrombocytopenia after chemotherapy for advanced ovarian cancer
Authors: Yamamoto, K Yajima, A Terashima, Y Nozawa, S Taketani, Y Yakushiji, M Noda, K
Citation: K. Yamamoto et al., Phase II clinical study on the effects of recombinant human interleukin-3 on thrombocytopenia after chemotherapy for advanced ovarian cancer, J IMMUNOTH, 22(6), 1999, pp. 539-545
Novel photolytic decomposition method of organic compounds with a high output low-pressure mercury lamp for voltammetric trace metal analysis
Authors: Yokoi, K Yakushiji, M Hatanaka, M Kubono, K Koide, T
Citation: K. Yokoi et al., Novel photolytic decomposition method of organic compounds with a high output low-pressure mercury lamp for voltammetric trace metal analysis, FRESEN J AN, 365(4), 1999, pp. 364-367
Solitary splenic recurrence of ovarian cancer: case report and review of the literature
Authors: Ushijima, K Nishida, T Okura, N Sugiyama, T Komai, K Tanaka, H Ohbuchi, M Okuda, K Tanaka, M Yakushiji, M
Citation: K. Ushijima et al., Solitary splenic recurrence of ovarian cancer: case report and review of the literature, ARCH GYN OB, 263(1-2), 1999, pp. 79-81
A loop test to measure the strength of monofilaments used for advanced composites
Authors: Fukuda, H Yakushiji, M Wada, A
Citation: H. Fukuda et al., A loop test to measure the strength of monofilaments used for advanced composites, ADV COM MAT, 8(3), 1999, pp. 281-291
Phase II dose escalation: A novel approach to balancing efficacy and toxicity of anticancer agents
Authors: Fujiwara, K Kohno, I Tanaka, K Ogita, S Sasaki, Y Hirabayashi, K Yakushiji, M Tsunematsu, R Terashima, Y Taguchi, T Ohashi, Y Noda, K
Citation: K. Fujiwara et al., Phase II dose escalation: A novel approach to balancing efficacy and toxicity of anticancer agents, ANTICANC R, 19(1B), 1999, pp. 639-644
The fusion of three primary incisors: Report of case
Authors: Mochizuki, K Yonezu, T Yakushiji, M Machida, Y
Citation: K. Mochizuki et al., The fusion of three primary incisors: Report of case, J DENT CHIL, 66(6), 1999, pp. 421
Radical surgery after neoadjuvant intra-arterial chemotherapy in stage IIIb squamous cell carcinoma of the cervix
Authors: Sugiyama, T Nishida, T Muraoka, Y Tokuda, T Kuromatsu, H Fujiyoshi, K Yakushiji, M Edamitu, O Haynbuchi, N
Citation: T. Sugiyama et al., Radical surgery after neoadjuvant intra-arterial chemotherapy in stage IIIb squamous cell carcinoma of the cervix, INT SURG, 84(1), 1999, pp. 67-73
Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer
Authors: Kigawa, J Takahashi, M Minagawa, Y Oishi, T Sugiyama, T Yakushiji, M Terakawa, N
Citation: J. Kigawa et al., Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer, INT J CANC, 84(5), 1999, pp. 521-524
Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
Authors: Sugiyama, T Nishida, T Kumagai, S Nishio, S Fujiyoshi, K Okura, N Yakushiji, M Hiura, M Umesaki, N
Citation: T. Sugiyama et al., Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer, BR J CANC, 81(1), 1999, pp. 95-98
Effects of a gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo
Authors: Maruuchi, T Sugiyama, T Kataoka, A Nishida, T Yakushiji, M
Citation: T. Maruuchi et al., Effects of a gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo, JPN J CANC, 89(9), 1998, pp. 977-983
Risultati: 1-15 |